I would like to make another comment about my post
Post# of 148298
We have 50 of 75 required for the Phase 2 Mild to Moderate trial.
And we have 37 of 50 required for the interim results of the Phase 2b/3 Severe to Critical trial.
For reasons that nearly everyone on the board already knows, we will finish enrollment in the Phase 2b/3 BEFORE we finish the enrollment of the Phase 2.
Given that fact, why does NP repeatedly (including in the audio clip I provided) present a timeline of events that has the results from the Phase 2 Mild to Moderate being presented BEFORE the Phase 2b/3?
I would think the company would seek approval of any indication it could -- as soon as it could.